CHARLES RIVER LABORATORIES (CRL:NYSE)

$301.77 -0.02 (-0.0066%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 76

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CHARLES RIVER LABORATORIES (CRL:NYSE) News Sources

Global Experimental Animal Model Market Outlook and Forecast, 2026-2032 - AI-Enabled Research and Advanced Transgenic and Oncology Models Drive 9.18% CAGR Toward US$2.23 Billion, With Charles River, The Jackson Laboratory, Taconic Biosciences and Crown Bioscience Profiled

29-09-2026

yahoo.com

NorthStrive Biosciences Partners with Charles River Laboratories to Advance Its EL-22 and EL-32 Engineered Probiotic Programs

29-09-2026

yahoo.com

Computer-Aided Drug Discovery - Global Strategic Business Report: Capitalize on 11% CAGR as AI-led CADD surges from $3.2B in 2025 to $6.7B by 2032—benchmark Bayer, Charles River Laboratories, Pharmaron and Chemical Computing Group to secure growth.

29-09-2026

yahoo.com

Pharmaceutical Impurity Synthesis and Isolation Services Report: Capitalize on a $2.1 Billion Market by 2030 as Tariffs and 8.9% Isolation Growth Reshape Competition Across Eurofins, WuXi AppTec, Cambrex and Charles River

29-09-2026

yahoo.com

Demand Stabilization Fuels Charles River Laboratories International’s (CRL) Recovery

29-09-2026

yahoo.com

Animal Model - Global Strategic Business Report: Market Size to Surge to $3.6 Billion by 2032 as CRISPR Disrupts R&D - Benchmark Charles River, Biocytogen, Crown Bioscience, Cyagen and The Jackson Laboratory

30-09-2026

yahoo.com

Charles River Laboratories (CRL) Stock Fair Value Rises After Analyst Day Target Increases

02-10-2026

yahoo.com

Charles River and Autolomous Partner to Transform Laboratory Execution Systems

06-10-2026

yahoo.com

Charles River Laboratories Schedules Third-Quarter 2026 Earnings Release and Conference Call

09-10-2026

yahoo.com

Global Synthetic Antibody Library Market Report 2026: Size and Forecast to 2030 | Capitalize on 12% CAGR and AI Design with Charles River, Twist Bioscience, GenScript and AbCellera

12-10-2026

yahoo.com

CHARLES RIVER LABORATORIES (CRL:NYSE) Sentiment Trend

0 25 50 75 100 72 81 82 80 74 81 69 89 52 80 29-09-2026 30-09-2026 02-10-2026 06-10-2026 09-10-2026 12-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CHARLES RIVER LABORATORIES (CRL:NYSE) FAQs

toggle

What is the current price of CHARLES RIVER LABORATORIES (CRL:NYSE)?

The current price of CHARLES RIVER LABORATORIES (CRL:NYSE) is $301.77.


toggle

CHARLES RIVER LABORATORIES (CRL:NYSE) absolute price change since previous trading day?

The absolute price change of CHARLES RIVER LABORATORIES (CRL:NYSE) since the previous trading day is $-0.02.


toggle

CHARLES RIVER LABORATORIES (CRL:NYSE) percentage price change since previous trading day?

The percentage price change of CHARLES RIVER LABORATORIES (CRL:NYSE) since the previous trading day is -0.0066%.


toggle

What is the most recent average sentiment score for CHARLES RIVER LABORATORIES (CRL:NYSE)?

The most recent average sentiment score for CHARLES RIVER LABORATORIES (CRL:NYSE) is 76 out of 100.


toggle

What is the most recent average sentiment for CHARLES RIVER LABORATORIES (CRL:NYSE)?

The most recent sentiment for CHARLES RIVER LABORATORIES (CRL:NYSE) is .


SEC-8K** Filing Available For CHARLES RIVER LABORATORIES (CRL:NYSE)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.